Cubist Systematic Strategies, LLC Allakos Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Allakos Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 7,568 shares of ALLK stock, worth $9,762. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,568

Previous 55,486 86.36%

Holding current value

$9,762

Previous $55,000 92.73%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.54 - $0.92 $25,875 - $44,084	-47,918 Reduced 86.36%	7,568 $4,000
Q2 2024 Aug 14, 2024	BUY	$1.0 - $1.45 $55,486 - $80,454	55,486 New	55,486 $55,000
Q4 2023 Feb 14, 2024	BUY	$1.72 - $3.18 $148,853 - $275,206	86,543 New	86,543 $236,000
Q1 2023 May 15, 2023	BUY	$4.3 - $8.27 $443,265 - $852,512	103,085 Added 641.12%	119,164 $530,000
Q4 2022 Feb 14, 2023	SELL	$5.66 - $8.42 $1.39 Million - $2.07 Million	-246,019 Reduced 93.87%	16,079 $135,000
Q3 2022 Nov 14, 2022	BUY	$3.02 - $6.12 $470,676 - $953,820	155,853 Added 146.69%	262,098 $1.6 Million
Q2 2022 Aug 15, 2022	SELL	$2.6 - $6.14 $309,150 - $730,070	-118,904 Reduced 52.81%	106,245 $333,000
Q1 2022 May 16, 2022	BUY	$5.08 - $9.81 $843,584 - $1.63 Million	166,060 Added 281.03%	225,149 $1.28 Million
Q4 2021 Feb 14, 2022	BUY	$8.55 - $111.89 $440,812 - $5.77 Million	51,557 Added 684.51%	59,089 $578,000
Q3 2021 Nov 15, 2021	SELL	$76.53 - $110.43 $2.78 Million - $4.01 Million	-36,303 Reduced 82.82%	7,532 $797,000
Q2 2021 Aug 16, 2021	BUY	$85.37 - $114.1 $3.63 Million - $4.85 Million	42,489 Added 3156.69%	43,835 $3.74 Million
Q1 2021 May 17, 2021	SELL	$109.73 - $153.66 $444,845 - $622,937	-4,054 Reduced 75.07%	1,346 $154,000
Q4 2020 Feb 16, 2021	BUY	$79.58 - $152.45 $136,161 - $260,841	1,711 Added 46.38%	5,400 $756,000
Q3 2020 Nov 16, 2020	BUY	$66.43 - $90.99 $245,060 - $335,662	3,689 New	3,689 $300,000
Q2 2020 Aug 14, 2020	SELL	$44.04 - $80.69 $405,432 - $742,832	-9,206 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$44.49 - $93.39 $245,718 - $515,792	5,523 Added 149.96%	9,206 $410,000
Q4 2019 Feb 14, 2020	SELL	$66.49 - $137.73 $63,431 - $131,394	-954 Reduced 20.57%	3,683 $351,000
Q3 2019 Nov 14, 2019	BUY	$31.0 - $89.73 $143,747 - $416,078	4,637 New	4,637 $365,000

Others Institutions Holding ALLK

# of Institutions

Shares Held

64.7M

Call Options Held

47.1K

Put Options Held

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $109M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Allakos Inc. Transaction History